Financial results - SALIX PHARM SRL

Financial Summary - Salix Pharm Srl
Unique identification code: 14602960
Registration number: J34/145/2002
Nace: 4773
Sales - Ron
276.238
Net Profit - Ron
22.919
Employees
5
Open Account
Company Salix Pharm Srl with Fiscal Code 14602960 recorded a turnover of 2024 of 276.238, with a net profit of 22.919 and having an average number of employees of 5. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Salix Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 70.298 73.693 86.493 100.923 107.516 80.406 147.502 187.814 205.373 276.238
Total Income - EUR 70.298 73.693 86.493 100.923 107.516 87.416 160.544 207.828 262.026 312.967
Total Expenses - EUR 70.231 73.622 84.527 99.649 105.156 93.516 156.905 204.928 257.865 285.786
Gross Profit/Loss - EUR 67 71 1.965 1.274 2.361 -6.100 3.639 2.901 4.161 27.181
Net Profit/Loss - EUR 56 59 1.167 265 1.285 -6.974 2.034 824 1.888 22.919
Employees 4 4 4 4 4 3 3 6 11 5
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 35.3%, from 205.373 euro in the year 2023, to 276.238 euro in 2024. The Net Profit increased by 21.041 euro, from 1.888 euro in 2023, to 22.919 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Salix Pharm Srl

Rating financiar

Financial Rating -
SALIX PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Salix Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Salix Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Salix Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Salix Pharm Srl - CUI 14602960

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 0 0 0 0 0 21.540 20.300 20.264 19.708 21.166
Current Assets 20.810 19.163 27.222 26.976 19.973 60.876 51.237 71.410 48.713 77.227
Inventories 12.532 11.164 12.769 10.216 5.413 29.221 13.462 30.944 28.602 59.668
Receivables 6.494 2.789 13.125 15.825 11.617 29.385 26.746 29.298 11.876 9.983
Cash 1.784 5.211 1.328 936 2.943 2.270 11.029 11.167 8.235 7.577
Shareholders Funds 45 44 44 43 42 -6.870 -4.684 -3.875 -1.975 20.956
Social Capital 45 45 44 43 42 0 0 0 0 0
Debts 22.970 21.547 29.565 27.564 19.931 89.285 76.221 95.548 70.395 77.437
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 77.227 euro in 2024 which includes Inventories of 59.668 euro, Receivables of 9.983 euro and cash availability of 7.577 euro.
The company's Equity was valued at 20.956 euro, while total Liabilities amounted to 77.437 euro. Equity increased by 22.919 euro, from -1.975 euro in 2023, to 20.956 in 2024.

Risk Reports Prices

Reviews - Salix Pharm Srl

Comments - Salix Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.